Funder
Swedish Brain Power
The Swedish Alzheimer Foundation
The Torsten Söderberg foundation
The Swedish Dementia Association
Gun and Bertil Stohne´s Foundation
Gamla Tjänarinnors Foundation
The Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet
The Swedish Research Council
Karolinska Institutet PhD-student funding
King Gustaf V and Queen Victoria’s Free Mason Foundation
Publisher
Springer Science and Business Media LLC
Subject
Cognitive Neuroscience,Neurology (clinical),Neurology
Reference35 articles.
1. Hardy J, Selkoe DJ. Medicine—The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–6.
2. Zetterberg H, Blennow K, Hanse E. Amyloid beta and APP as biomarkers for Alzheimer's disease. Exp Gerontol. 2010;45(1):23–9.
3. O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. In: Hyman SE, Jessell TM, Shatz CJ, Stevens CF, Zoghbi HY, editors. Annual Review of Neuroscience, vol. 34. Palo Alto: Annual Reviews; 2011. p. 185–204.
4. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, et al. A pathogenic mutation for probable Alzheimers-disease in the APP gene at the N-terminus of beta-amyloid. Nature Genet. 1992;1(5):345–7.
5. Axelman K, Basun H, Winblad B, Lannfelt L. A large Swedish family with Alzheimers-disease with a codon-670/671 amyloid precursor protein mutation—a clinical and genealogical investigation. Arch Neurol. 1994;51(12):1193–7.
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献